Cerus - 22 Year Stock Price History | CERS

Historical daily share price chart and data for Cerus since 1997 adjusted for splits. The latest closing stock price for Cerus as of October 17, 2019 is 4.45.
  • The all-time high Cerus stock closing price was 80.50 on December 28, 2000.
  • The Cerus 52-week high stock price is 6.88, which is 54.6% above the current share price.
  • The Cerus 52-week low stock price is 4.29, which is 3.6% below the current share price.
  • The average Cerus stock price for the last 52 weeks is 5.58.
Cerus Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 5.5762 5.3400 6.8500 4.3000 4.4500 -12.23%
2018 5.9496 3.5600 7.7800 3.5600 5.0700 50.00%
2017 3.3151 4.3300 4.6100 2.0200 3.3800 -22.30%
2016 5.8151 6.2400 7.3900 4.2200 4.3500 -31.17%
2015 5.0900 6.5150 6.5900 3.8600 6.3200 1.28%
2014 4.7555 6.4800 7.9500 3.5000 6.2400 -3.26%
2013 5.0364 3.1900 6.9400 2.9500 6.4500 104.11%
2012 3.3740 2.8600 4.3200 2.7600 3.1600 12.86%
2011 2.7593 2.4800 3.5700 1.9800 2.8000 13.82%
2010 2.8919 1.8000 3.9300 1.7800 2.4600 23.62%
2009 1.4225 0.8200 2.9800 0.6200 1.9900 184.29%
2008 4.3830 6.5600 7.2400 0.5800 0.7000 -89.25%
2007 6.9439 5.6800 10.1800 5.1300 6.5100 11.09%
2006 7.9441 10.0100 14.4800 5.3100 5.8600 -42.27%
2005 5.7493 3.1000 11.3300 3.0500 10.1500 244.07%
2004 2.9397 4.5000 4.7100 1.8500 2.9500 -35.02%
2003 7.4819 21.7200 21.7200 3.4000 4.5400 -78.88%
2002 33.4212 46.7700 58.6800 11.8700 21.5000 -53.01%
2001 55.9461 69.7500 75.3500 33.6300 45.7500 -39.20%
2000 49.3281 24.8800 80.5000 24.8800 75.2500 183.96%
1999 23.9083 20.5000 31.2500 15.4400 26.5000 26.19%
1998 16.4552 22.0000 23.7500 12.0000 21.0000 -4.55%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.624B $0.061B
Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $145.598B 26.57
Medtronic (MDT) Ireland $145.585B 20.43
Stryker (SYK) United States $80.642B 27.89
Boston Scientific (BSX) United States $53.170B 25.79
Baxter (BAX) United States $44.852B 27.20
EssilorLuxottica Societe Anonyme (ESLOY) France $32.725B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.438B 18.20
Coloplast (CLPBY) Denmark $25.747B 41.10
Lonza Group Ag (LZAGY) Switzerland $25.481B 0.00
Terumo (TRUMY) Japan $24.495B 30.57
Smith & Nephew SNATS (SNN) United Kingdom $20.928B 0.00
ResMed (RMD) United States $18.924B 36.06
Sunny Optical Technology (SNPTF) China $16.014B 0.00
Bio-Rad Laboratories (BIO) United States $10.234B 54.86
Insulet (PODD) United States $9.431B 558.86
Perrigo (PRGO) Ireland $7.400B 13.63
Canopy Growth (CGC) Canada $7.222B 0.00
Hill-Rom Holdings (HRC) United States $6.830B 20.36
Haemonetics (HAE) United States $6.455B 48.71
William Demant Holdings (WILYY) Denmark $5.988B 0.00
GN STORE NORD (GNNDY) Denmark $5.344B 27.61
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Aurora Cannabis (ACB) Canada $4.002B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.680B 0.00
Neogen (NEOG) United States $3.490B 58.40
NuVasive (NUVA) United States $3.398B 27.09
ICU Medical (ICUI) United States $3.237B 21.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.634B 0.00
Quidel (QDEL) United States $2.510B 24.93
Agios Pharmaceuticals (AGIO) United States $1.982B 0.00
National Vision Holdings (EYE) United States $1.877B 40.51
Cardiovascular Systems (CSII) United States $1.670B 0.00
Aphria (APHA) $1.242B 0.00
VAREX IMAGING (VREX) United States $1.124B 25.90
AtriCure (ATRC) United States $1.059B 0.00
Phibro Animal Health (PAHC) United States $0.867B 14.10
Eagle Pharmaceuticals (EGRX) United States $0.854B 21.78
NanoString Technologies (NSTG) United States $0.787B 0.00
Omeros (OMER) United States $0.759B 0.00
Lantheus Holdings (LNTH) United States $0.734B 19.29
PetIQ (PETQ) United States $0.725B 17.13
LeMaitre Vascular (LMAT) United States $0.689B 40.82
Surmodics (SRDX) United States $0.621B 118.00
MacroGenics (MGNX) United States $0.560B 0.00
Quanterix (QTRX) United States $0.548B 0.00
TG Therapeutics (TGTX) United States $0.530B 0.00
OraSure Technologies (OSUR) United States $0.523B 24.23
Owens & Minor (OMI) United States $0.459B 13.76
Meridian Bioscience (VIVO) United States $0.427B 13.32
Utah Medical Products (UTMD) United States $0.354B 25.91
Zynex (ZYXI) United States $0.346B 36.76
BioLife Solutions (BLFS) United States $0.339B 104.19
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.327B 0.00
Bovie Medical (APYX) United States $0.234B 0.00
United Health Products (UEEC) United States $0.208B 0.00
Vapotherm (VAPO) United States $0.177B 0.00
Rockwell Medical (RMTI) United States $0.153B 0.00
Cytosorbents (CTSO) United States $0.147B 0.00
Female Health (VERU) United States $0.138B 0.00
Fonar (FONR) United States $0.133B 9.32
InfuSystems Holdings (INFU) United States $0.127B 0.00
Liberty Health Sciences (LHSIF) Canada $0.104B 0.00
Chembio Diagnostics (CEMI) United States $0.097B 0.00
Chimerix (CMRX) United States $0.088B 0.00
Nephros (NEPH) United States $0.087B 0.00
United-Guardian (UG) United States $0.084B 19.82
MTech Acquisition (KERN) United States $0.063B 0.00
MRI Interventions (MRIC) United States $0.058B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.053B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
Surface Oncology (SURF) United States $0.039B 0.00
Senestech (SNES) United States $0.023B 0.00
Trinity Biotech (TRIB) Ireland $0.020B 0.00
GUARDION HEALTH (GHSI) United States $0.018B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.013B 0.00
Myomo (MYO) United States $0.010B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00